atomoxetine
Sign in to saveAtomoxetine, sold under the brand name Strattera, is a selective norepinephrine reuptake inhibitor (sNRI) medication used to treat attention deficit hyperactivity disorder (ADHD) and, to a lesser extent, cognitive disengagement syndrome (CDS). It may be used alone or along with psychostimulant medication. It enhances the executive functions of self-motivation, sustained attention, inhibition, working memory, reaction time, and emotional self-regulation. Use of atomoxetine is only recommended for those who are at least six years old. It is taken orally. The effectiveness of atomoxetine is compa
Key facts
- Drug.Verifiedfields
- changed
- Drug.Watchedfields
- changed
- Drug.verifiedrevid
- 458780865
- Drug.image
- Atomoxetine structure.svg
- Drug.image_class
- skin-invert-image
- Drug.width
- 220
- Drug.image2
- Atomoxetine ball-and-stick model.png
- Drug.image_class2
- bg-transparent
- Drug.width2
- 240
- Drug.tradename
- Strattera, others
- Drug.MedlinePlus
- a603013
- Drug.DailyMedID
- Atomoxetine
- Drug.pregnancy_AU
- B3
- Drug.routes_of_administration
- By mouth
- Drug.class
- Norepinephrine reuptake inhibitor
- Drug.ATC_prefix
- N06
- Drug.ATC_suffix
- BA09
- Drug.legal_AU
- S4
via Wikipedia infobox
Article
22 sectionsContents
- Medical uses
- Attention deficit hyperactivity disorder
- Other uses
- Cognitive disengagement syndrome
- Traumatic brain injury
- Contraindications
- Side effects
- Overdose
- Interactions
- Pharmacology
- Pharmacodynamics
- Pharmacokinetics
- Pharmacogenomics
- Chemistry
- Synthesis
- Detection in biological fluids
- History
- Society and culture
- Brand names
- Research
- References
- Further reading
Atomoxetine, sold under the brand name Strattera, is a selective norepinephrine reuptake inhibitor (sNRI) medication used to treat attention deficit hyperactivity disorder (ADHD) and, to a lesser extent, cognitive disengagement syndrome (CDS). It may be used alone or along with psychostimulant medication. It enhances the executive functions of self-motivation, sustained attention, inhibition, working memory, reaction time, and emotional self-regulation. Use of atomoxetine is only recommended for those who are at least six years old. It is taken orally. The effectiveness of atomoxetine is comparable to the commonly prescribed stimulant medication methylphenidate.
Common side effects of atomoxetine include abdominal pain, decreased appetite, nausea, feeling tired, and dizziness. Serious side effects may include angioedema, liver problems, stroke, psychosis, heart problems, suicide, and aggression. There is a lack of data regarding its safety during pregnancy; as of 2019, its safety during pregnancy and for use during breastfeeding is not certain.
Gallery (4)
Connections
Categories
2-Tolyl compoundsAttention deficit hyperactivity disorder managementChemical articles with multiple CAS registry numbersChemical articles with multiple ChEBIsChemical articles with multiple PubChem CIDsChemicals using indexlabelsDrugboxes which contain changes to verified fieldsDrugboxes which contain changes to watched fieldsDrugs developed by Eli Lilly and CompanyDrugs with non-standard legal status